Your browser doesn't support javascript.
loading
Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome.
Efe, Cumali; Kulkarni, Anand V; Terziroli Beretta-Piccoli, Benedetta; Magro, Bianca; Stättermayer, Albert; Cengiz, Mustafa; Clayton-Chubb, Daniel; Lammert, Craig; Bernsmeier, Christine; Gül, Özlem; la Tijera, Fatima Higuera-de; Anders, Margarita; Lytvyak, Ellina; Akin, Mete; Purnak, Tugrul; Liberal, Rodrigo; Peralta, Mirta; Ebik, Berat; Duman, Serkan; Demir, Nurhan; Balaban, Yasemin; Urzua, Álvaro; Contreras, Fernando; Venturelli, Maria Grazia; Bilgiç, Yilmaz; Medina, Adriana; Girala, Marcos; Günsar, Fulya; Londoño, Maria-Carlota; Androutsakos, Theodoros; Kisch, Ayelen; Yurci, Alper; Güzelbulut, Fatih; Çagin, Yasir Furkan; Avci, Enver; Akyildiz, Murat; Dindar-Demiray, Emine Kübra; Harputluoglu, Murat; Kumar, Rahul; Satapathy, Sanjaya K; Mendizabal, Manuel; Silva, Marcelo; Fagiuoli, Stefano; Roberts, Stuart K; Soylu, Nese Karadag; Idilman, Ramazan; Yoshida, Eric M; Montano-Loza, Aldo J; Dalekos, George N; Ridruejo, Ezequiel.
Afiliación
  • Efe C; Department of GastroenterologyHarran University HospitalSanliurfaTurkey.
  • Kulkarni AV; Department of Hepatology and Liver TransplantationAsian Institute of Gastroenterology HospitalsHyderabadIndia.
  • Terziroli Beretta-Piccoli B; Faculty of Biomedical SciencesUniversità Della Svizzera ItalianaLuganoSwitzerland.
  • Magro B; Epatocentro TicinoLuganoSwitzerland.
  • Stättermayer A; Gastroenterology Hepatology and TransplantationASST Papa Giovanni XXIII-BergamoBergamoItaly.
  • Cengiz M; Division of Gastroenterology and HepatologyDepartment of Internal Medicine IIIMedical University of ViennaViennaAustria.
  • Clayton-Chubb D; Department of GastroenterologyGülhane Training and Research HospitalAnkaraTurkey.
  • Lammert C; Department of GastroenterologyAlfred HealthMelbourneVictoriaAustralia.
  • Bernsmeier C; Department of Medicine IndianaUniversity School of MedicineIndianapolisIndianaUSA.
  • Gül Ö; Department of BiomedicineUniversity of BaselBaselSwitzerland.
  • la Tijera FH; University Centre for Gastrointestinal and Liver DiseasesBaselSwitzerland.
  • Anders M; Department of GastroenterologyKirikkale UniversityKirikkaleTurkey.
  • Lytvyak E; Gastroenterology and Hepatology UnitHospital General de MéxicoCiudad de MéxicoMexico.
  • Akin M; Hepatology and Liver Transplant UnitHospital AlemánCiudad Autónoma de Buenos AiresArgentina.
  • Purnak T; Division of Gastroenterology and Liver UnitUniversity of AlbertaEdmontonAlbertaCanada.
  • Liberal R; Department of GastroenterologyAkdeniz University Faculty of MedicineAntalyaTurkey.
  • Peralta M; Division of GastroenterologyHepatology and NutritionMcGovern Medical SchoolHoustonTexasUSA.
  • Ebik B; Gastroenterology and Hepatology DepartmentCentro Hospitalar e Universitário de São JoãoPortoPortugal.
  • Duman S; World Gastroenterology Organization (WGO) Porto Training CenterPortoPortugal.
  • Demir N; Hepatology SectionHospital Francisco J MuñizCiudad Autónoma de Buenos AiresArgentina.
  • Balaban Y; Latin American Liver Research Educational and Awareness Network (LALREAN)PilarArgentina.
  • Urzua Á; Department of GastroenterologyGazi Yasargil Education and Research HospitalDiyarbakirTurkey.
  • Contreras F; Department of GastroenterologyAnkara University Medical FacultyAnkaraTurkey.
  • Venturelli MG; Department of GastroenterologyHaseki Training and Research HospitalIstanbulTurkey.
  • Bilgiç Y; Department of GastroenterologyFaculty of MedicineHacettepe UniversityAnkaraTurkey.
  • Medina A; Gastroenterology and Hepatology UnitHospital Clínico Universidad de ChileSantiago de ChileChile.
  • Girala M; Centro de Gastroenterología AvanzadaSanta DomincoDominican Republic.
  • Günsar F; Gastroenterology and Hepatology UnitClinica Stella MarisLimaPeru.
  • Londoño MC; Department of GastroenterologyInönü University School of MedicineMalatyaTurkey.
  • Androutsakos T; Gastroenterology and Hepatology UnitHospital de Clínicas, Universidad Nacional de AsunciónSan LorenzoParaguay.
  • Kisch A; Gastroenterology and Hepatology UnitHospital de Clínicas, Universidad Nacional de AsunciónSan LorenzoParaguay.
  • Yurci A; Department of GastroenterologyEge University School of MedicineIzmirTurkey.
  • Güzelbulut F; Liver UnitHospital Clínic BarcelonaIDIBAPSCIBERehdBarcelonaSpain.
  • Çagin YF; Department of PathophysiologyNational and Kapodistrian University of AthensMedical SchoolAthensGreece.
  • Avci E; Hepatology SectionHospital Bonorino UdaondoCiudad Autónoma de Buenos AiresArgentina.
  • Akyildiz M; Department of GastroenterologyErciyes University School of MedicineKayseriTurkey.
  • Dindar-Demiray EK; Department of GastroenterologyHaydarpasa Numune Education and Research HospitalIstanbulTurkey.
  • Harputluoglu M; Department of GastroenterologyInönü University School of MedicineMalatyaTurkey.
  • Kumar R; Department of GastroenterologyKTO Karatay University Medical School Affiliated Konya Medicana HospitalKonyaTurkey.
  • Satapathy SK; Department of GastroenterologyKoc University School of MedicineIstanbulTurkey.
  • Mendizabal M; Department of Infectious Diseases and Clinical MicrobiologyBitlis Tatvan State HospitalBitlisTurkey.
  • Silva M; Department of GastroenterologyInönü University School of MedicineMalatyaTurkey.
  • Fagiuoli S; Department of Gastroenterology and HepatologyChangi General HospitalMedicine Academic Clinical ProgrammeSing Health Duke-NUS Academic Medical CentreSingapore.
  • Roberts SK; Department of Internal MedicineDonald and Barbara Zucker School of MedicineNorthwell HealthManhassetNew YorkUSA.
  • Soylu NK; Latin American Liver Research Educational and Awareness Network (LALREAN)PilarArgentina.
  • Idilman R; Hepatology and Liver Transplant UnitHospital Universitario AustralPilarArgentina.
  • Yoshida EM; Latin American Liver Research Educational and Awareness Network (LALREAN)PilarArgentina.
  • Montano-Loza AJ; Hepatology and Liver Transplant UnitHospital Universitario AustralPilarArgentina.
  • Dalekos GN; Gastroenterology Hepatology and TransplantationASST Papa Giovanni XXIII-BergamoBergamoItaly.
  • Ridruejo E; Department of GastroenterologyAlfred HealthMelbourneVictoriaAustralia.
Hepatology ; 76(6): 1576-1586, 2022 12.
Article en En | MEDLINE | ID: mdl-35567545
ABSTRACT
BACKGROUND AND

AIMS:

A few case reports of autoimmune hepatitis-like liver injury have been reported after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. We evaluated clinical features, treatment response and outcomes of liver injury following SARS-CoV-2 vaccination in a large case series. APPROACH AND

RESULTS:

We collected data from cases in 18 countries. The type of liver injury was assessed with the R-value. The study population was categorized according to features of immune-mediated hepatitis (positive autoantibodies and elevated immunoglobulin G levels) and corticosteroid therapy for the liver injury. We identified 87 patients (63%, female), median age 48 (range 18-79) years at presentation. Liver injury was diagnosed a median 15 (range 3-65) days after vaccination. Fifty-one cases (59%) were attributed to the Pfizer-BioNTech (BNT162b2) vaccine, 20 (23%) cases to the Oxford-AstraZeneca (ChAdOX1 nCoV-19) vaccine and 16 (18%) cases to the Moderna (mRNA-1273) vaccine. The liver injury was predominantly hepatocellular (84%) and 57% of patients showed features of immune-mediated hepatitis. Corticosteroids were given to 46 (53%) patients, more often for grade 3-4 liver injury than for grade 1-2 liver injury (88.9% vs. 43.5%, p = 0.001) and more often for patients with than without immune-mediated hepatitis (71.1% vs. 38.2%, p = 0.003). All patients showed resolution of liver injury except for one man (1.1%) who developed liver failure and underwent liver transplantation. Steroid therapy was withdrawn during the observation period in 12 (26%) patients after complete biochemical resolution. None had a relapse during follow-up.

CONCLUSIONS:

SARS-CoV-2 vaccination can be associated with liver injury. Corticosteroid therapy may be beneficial in those with immune-mediated features or severe hepatitis. Outcome was generally favorable, but vaccine-associated liver injury led to fulminant liver failure in one patient.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hepatitis Autoinmune / COVID-19 / Hepatitis A Tipo de estudio: Etiology_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Hepatology Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hepatitis Autoinmune / COVID-19 / Hepatitis A Tipo de estudio: Etiology_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Hepatology Año: 2022 Tipo del documento: Article